HomeREGULATORY
REGULATORY

CSIMC Recommends NHI Price Listing for 15 APIs/20 Products
(Sep.7.2011)

At a general meeting on September 7, the Central Social Insurance Medical Council (CSIMC; Chuikyo) recommended NHI price listing for 15 APIs (active pharmaceutical ingredients)/20 products, including AstraZeneca’s proton pump inhibitor (PPI) Nexium capsule 10 mg and 20 mg (esomeprazole magnesium) and Astellas Pharma’s treatment for overactive bladder Betanis Tablet 25 mg and 50 mg (mirabegron). The adrenal hormone preparation EpiPen Injection 0.15 mg and 0.3 mg (adrenaline) will be added to the NHI price list on September 22. Other products will be included in the NHI price list on September 12.
> Read full story

Commentary

Abe Pledges Biosimilar Promotion, but Doctor Misconception and Lack of Incentives Remain as Challenges

Lexicon

Annual NHI Drug Price Revisions:
毎年改定

The Column

When Interviewing, Share the Love

Archives

MHLW to Invite Candidate Products for “Sakigake” Designation System(Mar.31)
MHLW Reiterates Caution on Skin Disorders for Lamictal: Safety Bulletin(Mar.31)
Fujifilm to Buy US iPS Cell Manufacturer Cellular Dynamics(Mar.31)
New Stroke Guidelines to “Strongly Recommend” NOACs for NVAF(Mar.31)
Eisai’s Lenvima Gains Positive Opinion from CHMP(Mar.31)

Most Read

1.
Lawmakers to Fo...
2.
Kitasato Daiich...
3.
Nonpartisan Gro...
4.
Xtandi Signific...
5.
1st Generation ...

News Calendar